Blue Paradigm Pharmaceuticals Llp - Company Profile

It is a pharma limited liability partnership based in Navi Mumbai, Maharashtra, India, established in 2021.
2021 Navi Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Blue Paradigm Pharmaceuticals Llp

Blue Paradigm Pharmaceuticals Llp, a active limited liability partnership, was established on 14 May 2021 in Navi Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds LLPIN: AAX-0199. Registered under ROC Roc Mumbai. It has total obligation of contribution of ₹0.10 M.

Its leadership includes Avinash Shiv Singh Negi (Designated Partner), Kedar Avinash Vidhwans (Designated Partner). Its latest date of accounts and solvency statement 31 March 2025. It is based at Office No 1302, Building No A1, Sector 1, Mbp, Mahape, Navi Mumbai, Maharashtra, 400710.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAX-0199

  • Incorporation Date

    14 May 2021

  • Total Obligation of Contribution

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 0.10 M
  • Company Age 4 Year, 10 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Blue Paradigm Pharmaceuticals Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Blue Paradigm Pharmaceuticals Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Blue Paradigm Pharmaceuticals Llp?
Current Designated Partners
Name Designation Appointment Date Status
Avinash Shiv Singh Negi Designated Partner 14 May 2021 Current
Kedar Avinash Vidhwans Designated Partner 14 May 2021 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Blue Paradigm Pharmaceuticals Llp.

Enhance accessibility to Blue Paradigm Pharmaceuticals Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Blue Paradigm Pharmaceuticals Llp revenue growth over time
Blue Paradigm Pharmaceuticals Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Blue Paradigm Pharmaceuticals Llp?

Unlock access to Blue Paradigm Pharmaceuticals Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Blue Paradigm Pharmaceuticals Llp?

Unlock and access historical data on people associated with Blue Paradigm Pharmaceuticals Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Blue Paradigm Pharmaceuticals Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Blue Paradigm Pharmaceuticals Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Blue Paradigm Pharmaceuticals Llp
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Blue Paradigm Pharmaceuticals Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was documented.

  • Statement of Assets & Liabilities

    Blue Paradigm Pharmaceuticals Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.

  • Director Appointment

    Avinash Shiv Singh Negi was appointed as a Designated Partner was appointed as a Designated Partner on 14 May 2021 & has been associated with this company since 4 years 10 months . was recorded as a recent event.

  • Director Appointment

    The activity Kedar Avinash Vidhwans was appointed as a Designated Partner was appointed as a Designated Partner on 14 May 2021 & has been associated with this company since 4 years 10 months . was completed.

  • LLP Incorporation

    Progress on Blue Paradigm Pharmaceuticals Llp was registered on 14 May 2021 with Roc Mumbai & aged 4 years 10 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Blue Paradigm Pharmaceuticals Llp?

The LLPIN of Blue Paradigm Pharmaceuticals Llp is AAX-0199.

Where is Blue Paradigm Pharmaceuticals Llp headquartered?

Blue Paradigm Pharmaceuticals Llp is headquartered at Office No 1302, Building No A1, Sector 1, Mbp, Mahape, Navi Mumbai, Maharashtra, 400710.

When was Blue Paradigm Pharmaceuticals Llp incorporated?

Blue Paradigm Pharmaceuticals Llp was incorporated on 14 May 2021.

Who are the current directors of Blue Paradigm Pharmaceuticals Llp?

The current directors of Blue Paradigm Pharmaceuticals Llp are

What is the primary industry of Blue Paradigm Pharmaceuticals Llp?

The primary industry of Blue Paradigm Pharmaceuticals Llp is Pharma.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available